Ignite Creation Date:
2024-05-06 @ 3:17 PM
Last Modification Date:
2024-10-26 @ 1:47 PM
Study NCT ID:
NCT04587453
Status:
COMPLETED
Last Update Posted:
2022-09-22
First Post:
2020-09-29
Brief Title:
Tralokinumab in Combination With Topical Corticosteroids in Japanese Subjects With Moderate-to-severe Atopic Dermatitis
Sponsor:
LEO Pharma
Organization:
LEO Pharma
Organization Data
Organization:
LEO Pharma
Class:
INDUSTRY
Study ID:
LP0162-1343
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
LEO Pharma
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None